Hospital Readmission After HIPr Fracture. Impact of a Territorial Fracture Liason Service

NCT ID: NCT05266755

Last Updated: 2022-03-18

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 120 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-03-15
• Study Completion Date: 2023-04-01

Brief Summary

The International Osteoporosis Foundation (IOF) and the American Society for Bone Research and Mineral Metabolism recommend the creation and implementation of fracture coordination services (FLS) as the most efficient way to address the problem. FLS has emerged as a new clinical approach that uses coordinated, multidisciplinary care to improve post-fracture outcomes and reduce recurrent fractures. It is a multidisciplinary and protocolized care model that must guarantee:

1. Identify fragility fractures and people at risk for a fracture

2. Fracture risk assessment

3. Indication for treatment or referral

4. Improvement in therapeutic compliance

5. Reduce the risk of falls It is known that patients who have undergone a FLS model (vs no FLS), have lower mortality, lower risk of fracture, with a reduction of 35% and 56%, respectively, during two years of follow-up. One of the most important objectives of the FLS is the proper recognition and treatment of osteoporosis (OP) in patients with fragility fractures. A major problem is the lack of adherence to treatment for OP, and inclusion in an FLS program increases the prescription of bisphosphonates from 17.9% to 76%. In addition, a specific follow-up program means that 73% of patients followed by FLS continue to undergo anti-resorptive treatment after 2 years of having suffered a femur fracture.

Detailed Description

Hypothesis After a femur fracture due to fragility, upon discharge from surgery at the Hospital de la Santa Creu i Sant Pau, including patients in a regional FLS program will make it possible to complete the study of the patient with fracture, improve adherence to treatment of OP (secondary prevention), and obtain better functional recovery.

Conditions

Hip Fractures

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Patiens who will receive stanrdar care after hip fracture

All the patients who will be on surgery after a hip fracture will receive after the hospital discharge the standar following we are doing now in our hospital

Group Type: PLACEBO_COMPARATOR

Fracture Territorial Liaison Service afert a Hip fracture

Intervention Type: OTHER

Give a diferent than the current one way of follow up to the patients with hip fracture

Patiens who will receive FLS following after the hip fracture

All the patients who will be on surgery after a hip fracture will receive after the hospital discharge a FLS following, multidisciplinary, with a web and mobile app aplication

Group Type: ACTIVE_COMPARATOR

Fracture Territorial Liaison Service afert a Hip fracture

Intervention Type: OTHER

Give a diferent than the current one way of follow up to the patients with hip fracture

Interventions

Fracture Territorial Liaison Service afert a Hip fracture

Give a diferent than the current one way of follow up to the patients with hip fracture

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• All hip fractures older than 65 years

Exclusion Criteria

• Politraumatic fractures
• Metastasic fractures

• Minimum Eligible Age: 65 Years
• Maximum Eligible Age: 99 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Jordi Martin Marcuello

Barcelona, Catalonia, Spain

Countries

Spain

Central Contacts

Jordi M Marcuello, Doctor

Role: CONTACT

jmartinma@santpau.cat

629315207

Facility Contacts

Jordi M Marcuello

Role: primary

jmartinma@santpau.cat

629315207

Role: backup

jmartinma@santpau.cat

Other Identifiers

IIBSP-FLS-2021-114

Identifier Type: -

Identifier Source: org_study_id